Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_17512 | 12 | 0.25 | Mlig455_062183 | Neo: - Age: - |
ASAP1 | Mlig455_062183 {REF} {Length: 2038} {Pfam: BAR domain of APPL family [PF16746.7, score=36.8]} {Human: ENSG00000153317, ASAP1, ArfGAP with SH3 domain, ankyrin repeat and PH domain 1, [Score=111, Expect=9e-28]} {Mouse: ENSMUSG00000022377, Asap1, ArfGAP with SH3 domain, ankyrin repeat and PH domain1, [Score=111, Expect=5e-28]} {Dmel: FBgn0050372, Asap, ArfGAP with SH3 domain, ankyrin repeat and PH domain, [Score=82.0, Expect=6e-18]} {Smed: dd_Smed_v6_6590_0_1, dd_Smed_v6_6590_0_1, [Score=105, Expect=4e-26]} {RNA1509_9697} {RNA1310_22007} {RNA815_556} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -0.92 | 0.807 | 0.99991 | 1.00000 | |
RegionR2 | 2.254 | 0.807 | 0.73335 | 1.00000 | |
RegionR3 | -1.32 | 0.807 | 0.99981 | 1.00000 | |
RegionR4 | 3.592 | 0.807 | 0.16190 | 0.42039 | |
RegionR5 | 0.457 | 0.807 | 0.49008 | 0.85339 | |
RegionR6 | -1.155 | 0.807 | 0.99980 | 1.00000 | |
RegionR7 | -1.366 | 0.807 | 0.99992 | 1.00000 | |
RegionR8 | -1.542 | 0.807 | 0.99992 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 1.534 | 0.807 | 1.00000 | 1.00000 | |
RegenerationR2 | 0.155 | 0.807 | 0.66834 | 0.94437 | |
RegenerationR3 | 2.533 | 0.807 | 0.48695 | 0.85338 | |
RegenerationR4 | -0.065 | 0.807 | 0.89152 | 1.00000 | |
RegenerationR5 | 0.431 | 0.807 | 0.94902 | 1.00000 | |
RegenerationR6 | 1.471 | 0.807 | 1.00000 | 1.00000 | |
RegenerationBL | 1.52 | 0.807 | 0.99981 | 1.00000 | |
RegenerationTP | 1.083 | 0.807 | 0.99984 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_17512 | 12 | 0.25 | Mlig455_062183 | Neo: - Age: - |
ASAP1 | 3 | 1.000 | 1.000 | - | - | - | 1.000 | Mlig455_062183 {REF} {Length: 2038} {Pfam: BAR domain of APPL family [PF16746.7, score=36.8]} {Human: ENSG00000153317, ASAP1, ArfGAP with SH3 domain, ankyrin repeat and PH domain 1, [Score=111, Expect=9e-28]} {Mouse: ENSMUSG00000022377, Asap1, ArfGAP with SH3 domain, ankyrin repeat and PH domain1, [Score=111, Expect=5e-28]} {Dmel: FBgn0050372, Asap, ArfGAP with SH3 domain, ankyrin repeat and PH domain, [Score=82.0, Expect=6e-18]} {Smed: dd_Smed_v6_6590_0_1, dd_Smed_v6_6590_0_1, [Score=105, Expect=4e-26]} {RNA1509_9697} {RNA1310_22007} {RNA815_556} |
2. | MligTC455_54121 | 71 | 1.47 | Mlig455_068380 | Neo: Irradiation Age: Up-Down-Up Region-enriched R4: 3.953/0.00195 |
1.742 | - | 0.958 | - | - | - | 0.784 | Mlig455_068380 {REF} {Length: 2027} {RNA1509_41665, RNA1509_4855} {RNA1310_14711, RNA1509_41665} {RNA1509_41665, RNA815_5379} | |
3. | MligTC455_53827 | 41 | 0.85 | Mlig455_057728 | Neo: - Age: - Region-enriched R2: 6.363/0.00033 |
1.733 | 0.976 | - | - | - | - | 0.757 | Mlig455_057728 {REF} {Length: 1074} {RNA1310_41119} {RNA815_15825} | |
4. | MligTC455_37412 | 95 | 1.98 | Mlig455_036605, Mlig455_036645 | Neo: - Age: - |
ADRA2A | 1.731 | 0.778 | - | - | - | - | 0.953 | Mlig455_036605 {REF} {Length: 3015} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.8]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=2e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=5e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=64.7, Expect=1e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=7e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=5e-35]} {RNA1310_57451} {RNA815_47300} Mlig455_036645 {REF} {Length: 3203} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.0]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=1e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=4e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=63.2, Expect=4e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=6e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=6e-35]} {RNA1310_57451} {RNA815_47300} |
5. | MligTC455_05082 | 15 | 0.32 | Mlig455_069987 | Neo: - Age: - |
0.97 | - | 0.970 | - | - | - | - | Mlig455_069987 {REF} {Length: 1509} {RNA1310_38226.2} {RNA815_25750} | |
6. | MligTC455_26175 | 77 | 1.61 | Mlig455_001462, Mlig455_004850, Mlig455_030045, Mlig455_039017 | Neo: - Age: - Region-enriched R2: 5.289/0.03235 |
NYNRIN | 0.967 | - | 0.967 | - | - | - | - | Mlig455_001462 {REF} {Length: 3779} {Pfam: RNase H-like domain found in reverse transcriptase [PF17919.3, score=102.0]; RNase H-like domain found in reverse transcriptase [PF17917.3, score=96.4]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=70.1]; Integrase zinc binding domain [PF17921.3, score=52.3]; Integrase core domain [PF00665.28, score=49.4]; gag-polyprotein putative aspartyl protease [PF13975.8, score=45.5]; Aspartyl protease [PF13650.8, score=33.1]; Retroviral aspartyl protease [PF00077.22, score=19.5]} {Human: ENSG00000205978, NYNRIN, NYN domain and retroviral integrase containing, [Score=77.0, Expect=2e-13]} {Mouse: ENSMUSG00000075592, Nynrin, NYN domain and retroviral integrase containing, [Score=77.8, Expect=8e-14]} {Smed: dd_Smed_v6_6563_0_1, dd_Smed_v6_6563_0_1, [Score=271, Expect=2e-75]} {RNA1509_38388} {RNA1310_4763.1} {RNA815_16141} Mlig455_004850 {REF} {Length: 4349} {Pfam: RNase H-like domain found in reverse transcriptase [PF17919.3, score=102.0]; RNase H-like domain found in reverse transcriptase [PF17917.3, score=96.4]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=70.1]; Integrase zinc binding domain [PF17921.3, score=52.3]; Integrase core domain [PF00665.28, score=49.4]; gag-polyprotein putative aspartyl protease [PF13975.8, score=45.5]; Aspartyl protease [PF13650.8, score=33.1]; Retroviral aspartyl protease [PF00077.22, score=19.5]} {Human: ENSG00000205978, NYNRIN, NYN domain and retroviral integrase containing, [Score=77.0, Expect=2e-13]} {Mouse: ENSMUSG00000075592, Nynrin, NYN domain and retroviral integrase containing, [Score=77.8, Expect=8e-14]} {Smed: dd_Smed_v6_6563_0_1, dd_Smed_v6_6563_0_1, [Score=271, Expect=2e-75]} {RNA1509_38388} {RNA1310_4763.1} {RNA815_16141} Mlig455_030045 {REF} {Length: 4782} {Pfam: RNase H-like domain found in reverse transcriptase [PF17919.3, score=101.7]; RNase H-like domain found in reverse transcriptase [PF17917.3, score=96.6]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=70.6]; Integrase zinc binding domain [PF17921.3, score=52.5]; Integrase core domain [PF00665.28, score=49.6]; gag-polyprotein putative aspartyl protease [PF13975.8, score=44.5]; Aspartyl protease [PF13650.8, score=32.9]} {Human: ENSG00000205978, NYNRIN, NYN domain and retroviral integrase containing, [Score=78.6, Expect=5e-14]} {Mouse: ENSMUSG00000075592, Nynrin, NYN domain and retroviral integrase containing, [Score=77.8, Expect=6e-14]} {Smed: dd_Smed_v6_6563_0_1, dd_Smed_v6_6563_0_1, [Score=265, Expect=5e-74]} {RNA1509_38388, RNA1509_56442} {RNA1310_4763.1, RNA1509_38388, RNA1509_56442} {RNA1509_38388, RNA1509_56442, RNA815_16141} Mlig455_039017 {REF} {Length: 4349} {Pfam: RNase H-like domain found in reverse transcriptase [PF17919.3, score=101.9]; RNase H-like domain found in reverse transcriptase [PF17917.3, score=96.4]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=70.1]; Integrase zinc binding domain [PF17921.3, score=52.5]; Integrase core domain [PF00665.28, score=48.4]; gag-polyprotein putative aspartyl protease [PF13975.8, score=45.7]; Aspartyl protease [PF13650.8, score=32.2]; Retroviral aspartyl protease [PF00077.22, score=19.2]} {Human: ENSG00000205978, NYNRIN, NYN domain and retroviral integrase containing, [Score=76.6, Expect=3e-13]} {Mouse: ENSMUSG00000075592, Nynrin, NYN domain and retroviral integrase containing, [Score=76.6, Expect=2e-13]; ENSMUSG00000085925, Rtl1, retrotransposon Gaglike 1, [Score=73.6, Expect=2e-12]; ENSMUSG00000098639, Rtl1, retrotransposon Gaglike 1, [Score=73.6, Expect=2e-12]} {Smed: dd_Smed_v6_6563_0_1, dd_Smed_v6_6563_0_1, [Score=268, Expect=2e-74]} {RNA1509_38388} {RNA1310_4763.1} {RNA815_16141} |
7. | MligTC455_26255 | 126 | 2.63 | Mlig455_053706 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.424/0.00107 |
FZD5 | 0.965 | 0.965 | - | - | - | - | - | Mlig455_053706 {REF} {Length: 3671} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=393.1]; Fz domain [PF01392.24, score=105.2]} {Human: ENSG00000163251, FZD5, frizzled class receptor 5, [RH, Score=607, Expect=0.0]} {Mouse: ENSMUSG00000045005, Fzd5, frizzled class receptor 5, [RH, Score=600, Expect=0.0]} {Dmel: FBgn0016797, fz2, frizzled 2, [RH, Score=562, Expect=0.0]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [RH, Score=412, Expect=5e-137]} {Smed: dd_Smed_v6_11823_0_1, dd_Smed_v6_11823_0_1, [RH, Score=551, Expect=0.0]} {RNA1509_49831} {RNA1310_28187, RNA1509_49831} {RNA1509_49831, RNA815_16996} |
8. | MligTC455_40789 | 92 | 1.92 | Mlig455_031974 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.221/0.03165 |
PDE5A | 0.958 | 0.958 | - | - | - | - | - | Mlig455_031974 {REF} {Length: 4371} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=145.0]; GAF domain [PF01590.28, score=76.5]; GAF domain [PF13185.8, score=37.4]; GAF domain [PF13492.8, score=37.2]} {Human: ENSG00000138735, PDE5A, phosphodiesterase 5A, [Score=365, Expect=8e-112]; ENSG00000128655, PDE11A, phosphodiesterase 11A, [Score=358, Expect=4e-108]; ENSG00000284741, PDE11A, phosphodiesterase 11A, [Score=358, Expect=1e-110]} {Mouse: ENSMUSG00000053965, Pde5a, phosphodiesterase 5A, cGMP-specific, [Score=364, Expect=4e-111]; ENSMUSG00000075270, Pde11a, phosphodiesterase 11A, [Score=359, Expect=1e-108]} {Dmel: FBgn0085370, Pde11, Phosphodiesterase 11, [Score=389, Expect=4e-118]} {Celegans: WBGene00016328, pde-5, Probable 3',5'-cyclic phosphodiesterase pde-5, [Score=235, Expect=8e-66]} {Smed: dd_Smed_v6_8595_0_4, dd_Smed_v6_8595_0_4, [Score=400, Expect=2e-124]} {RNA1509_52520} {RNA1310_8630.1} {RNA815_26873} |
9. | MligTC455_23543 | 79 | 1.65 | Mlig455_021851 | Neo: - Age: - Region-enriched R2: 5.153/0.00077 |
MAP3K19 | 0.957 | 0.957 | - | - | - | - | - | Mlig455_021851 {REF} {Length: 7454} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=226.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=217.3]; Ankyrin repeats (3 copies) [PF12796.9, score=113.8]; Ankyrin repeats (many copies) [PF13637.8, score=82.7]; Ankyrin repeats (many copies) [PF13857.8, score=77.3]; F5/8 type C domain [PF00754.27, score=56.3]; Ankyrin repeat [PF00023.32, score=55.9]; Ankyrin repeat [PF13606.8, score=49.9]; ABC1 atypical kinase-like domain [PF03109.18, score=28.7]} {Human: ENSG00000176601, MAP3K19, mitogen-activated protein kinase kinase kinase 19, [Score=159, Expect=2e-40]} {Mouse: ENSMUSG00000051590, Map3k19, mitogen-activated protein kinase kinase kinase 19, [Score=164, Expect=3e-42]} {Dmel: FBgn0266465, GckIII, Germinal centre kinase III, [Score=146, Expect=1e-35]} {Celegans: WBGene00001526, gck-1, Germinal center kinase 1, [Score=139, Expect=2e-33]} {Smed: dd_Smed_v6_10339_0_1, dd_Smed_v6_10339_0_1, [Score=153, Expect=2e-37]} {RNA1509_46581} {RNA1310_9191} {RNA815_12161} |
10. | MligTC455_38012 | 17 | 0.35 | Mlig455_037323, Mlig455_040296 | Neo: - Age: - |
0.954 | - | - | - | - | - | 0.954 | Mlig455_037323 {REF} {Length: 405} {NoTransDecoderORF} {RNA1310_81014.1} Mlig455_040296 {REF} {Length: 180} {NoTransDecoderORF} {RNA1310_81014.2} |
|
11. | MligTC455_18748 | 104 | 2.17 | Mlig455_024985, Mlig455_024999 | Neo: - Age: - Region-enriched R2: 6.002/0.00016 |
GRIK4 | 0.951 | 0.951 | - | - | - | - | - | Mlig455_024985 {REF} {Length: 1514} {Pfam: Ligand-gated ion channel [PF00060.28, score=76.7]; Receptor family ligand binding region [PF01094.30, score=31.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=20.6]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=122, Expect=1e-27]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=124, Expect=1e-28]} {Dmel: FBgn0038837, CG3822, [Score=120, Expect=1e-27]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=99.0, Expect=5e-21]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=196, Expect=2e-55]} {RNA1509_35538} {RNA1310_47299} {RNA815_38321} Mlig455_024999 {REF} {Length: 3567} {Pfam: Ligand-gated ion channel [PF00060.28, score=76.7]; Receptor family ligand binding region [PF01094.30, score=31.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=20.6]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=122, Expect=1e-27]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=124, Expect=1e-28]} {Dmel: FBgn0038837, CG3822, [Score=120, Expect=1e-27]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=99.0, Expect=5e-21]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=196, Expect=2e-55]} {RNA1509_35538} {RNA1310_7578, RNA1509_35538} {RNA1509_35538, RNA815_4987} |